brusatol has been researched along with Injury, Myocardial Reperfusion in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, PS; Chen, YG; Cheng, Y; Hao, PP; Hu, B; Jiang, TY; Li, XT; Liu, WC; Tian, T; Xue, FS | 1 |
1 other study(ies) available for brusatol and Injury, Myocardial Reperfusion
Article | Year |
---|---|
Dexmedetomidine postconditioning attenuates myocardial ischemia/reperfusion injury by activating the Nrf2/Sirt3/SOD2 signaling pathway in the rats.
Topics: Animals; Apoptosis; Dexmedetomidine; Male; Myocardial Reperfusion Injury; NF-E2-Related Factor 2; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Reperfusion Injury; Signal Transduction; Sirtuin 3; Superoxide Dismutase | 2023 |